Scharf Investments, LLC Astrazeneca PLC Transaction History

Scharf Investments, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$59.26 - $71.14 $56.6 Million - $67.9 Million	-954,626 Reduced 84.86%	170,290 $11.3 Million
Q1 2022 Apr 13, 2022	BUY	$55.72 - $67.12 $2.39 Million - $2.88 Million	42,935 Added 3.97%	1,124,916 $74.6 Million
Q4 2021 Jan 20, 2022	BUY	$54.02 - $63.83 $6.26 Million - $7.4 Million	115,951 Added 12.0%	1,081,981 $63 Million
Q3 2021 Oct 14, 2021	BUY	$55.56 - $60.79 $53.7 Million - $58.7 Million	966,030 New	966,030 $58 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Scharf Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Scharf Investments, LLC with notifications on news.